Clinical Trial Update: A Study to Evaluate the Effects of Ezetimibe (MK-0653) on the Postprandial (Following a Meal) Lipoprotein Response in Participants With Primary Hypercholesterolemia (High Cholesterol) (MK-0653-072)(COMPLETED) [Phase 3]

View source ↗

Summary

A Phase 3 study assessing ezetimibe (MK-0653) effects on postprandial lipoprotein response in adults with primary hypercholesterolemia; the trial is completed a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• EZETIMIBE (EZETIMIBE)

Snippet

Sponsor: Organon and Co | Conditions: Hypercholesterolemia | Phase 3 | Status: COMPLETED | Results posted: 2016-06-10